Rituximab Fails to Reduce Histologic Transformation (HT) Rate of Follicular Lymphoma (FL) to Diffuse Large B-Cell Lymphoma (DLBCL)

被引：2
|
作者：
Marciscano, Ariel E. [1 ]
Gupta, Neel [2 ]
Zhang, Zhigang [2 ]
Teruya-Feldstein, Julie [2 ]
Noy, Ariela [2 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
10.1182/blood.V112.11.837.837
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：310 / 310
页数：1
相关论文
共 50 条
  • [31] A Cross-Sectional Study of Unmet Needs of Lymphoma Patients in Patient-Doctor Communication: Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL)
    Bamigbola, Olufunmilayo A.
    Dren, Natalie M.
    Warwick, Lorna E.
    BLOOD, 2019, 134
  • [32] Rituximab and chemotherapy in diffuse large B-cell lymphoma
    Sonet, Anne
    Bosly, Andre
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 719 - 726
  • [33] Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma
    Uryu, Hideki
    Mishima, Yuko
    Tsuyama, Naoko
    Yokoyama, Masahiro
    Nishimura, Noriko
    Fukuta, Takanori
    Shirouchi, Yuko
    Okabe, Takashi
    Inoue, Norihito
    Takeuchi, Kengo
    Terui, Yasuhito
    LEUKEMIA & LYMPHOMA, 2021, 62 (09) : 2141 - 2150
  • [34] Differences in Outcomes in Males and Females with Diffuse Large B-Cell Lymphoma with Induction Rituximab and Follicular Lymphoma Treated with Maintenance Rituximab
    Habermann, Thomas M.
    Hong, Fangxin
    Morrison, Vicki A.
    Dakhil, Shaker R.
    Weick, James K.
    Frankel, Stanley R.
    Gascoyne, Randy D.
    Fisher, Richard I.
    Cheson, Bruce D.
    Weller, Edie A.
    Kahl, Brad S.
    Peterson, Bruce A.
    Hochster, Howard S.
    Horning, Sandra J.
    BLOOD, 2012, 120 (21)
  • [35] Pembrolizumab with Rituximab in Relapsed/Refractory Follicular Lymphoma and Diffuse Large B Cell Lymphoma
    Ho, Carrie I.
    Gopal, Ajay K.
    Ujjani, Chaitra S.
    Lynch, Ryan C.
    Poh, Christina
    Voutsinas, Jenna M.
    Wu, Qian
    Vandermeer, Jacquelin
    Fromm, Jonathan R.
    Smith, Stephen D.
    BLOOD, 2023, 142
  • [36] Composite follicular (FL) and diffuse large B cell lymphoma (DLBCL): A gene expression profiling (GEP) study
    Farinha, P.
    Lee, M.
    Al-Tourah, A.
    Connors, J.
    Gascoyne, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 106 - 106
  • [37] Cutaneous annular lesions as the first sign of transformation of follicular lymphoma into diffuse large B-cell lymphoma
    Palacios-Alvarez, Irene
    Roman-Curto, Concepcion
    Martin Garcia-Sancho, Alejandro
    Santos-Briz, Angel
    Carlos Santos-Duran, Juan
    Fernandez-Lopez, Emilia
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2015, 81 (05): : 495 - 497
  • [38] Determining the mechanism of transformation of follicular lymphoma into diffuse large B cell lymphoma
    Carlotti, Emanuela
    Wrench, David
    Iqbal, Sameena
    O'Shea, Derville
    Davies, Andrew
    Virappane, Priya
    Hart, Jason
    Lai, Raymond
    Gribben, John G.
    Lister, Andrew T.
    Fitzgibbon, Jude
    BLOOD, 2007, 110 (11) : 61A - 61A
  • [39] ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
    Ghielmini, M.
    Vitolo, U.
    Kimby, E.
    Montoto, S.
    Walewski, J.
    Pfreundschuh, M.
    Federico, M.
    Hoskin, P.
    McNamara, C.
    Caligaris-Cappio, F.
    Stilgenbauer, S.
    Marcus, R.
    Trneny, M.
    Dreger, P.
    Montserrat, E.
    Dreyling, M.
    ANNALS OF ONCOLOGY, 2013, 24 (03) : 561 - 576
  • [40] Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma
    Coleman, Morton
    Lammers, Philip E.
    Ciceri, Fabio
    Jacobs, Ira A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (04): : 175 - 181
12345